Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Michael A. Metzger | Chief Executive Officer, Director | $9.99M | -$206K | -2.02% | Feb 10, 2025 |
Steve M. Sabus | Chief Commercial Officer | $5.69M | Dec 5, 2022 | ||
Dennis Podlesak | Director | $3.84M | Feb 5, 2025 | ||
Keith A. Goldan | Chief Financial Officer | $3.03M | -$33.5K | -1.1% | Feb 10, 2025 |
Neil Gallagher | President, Head of R&D | $2.94M | -$71.6K | -2.38% | Feb 10, 2025 |
Catherine Madigan | Chief Medical Officer | $2.84M | Feb 2, 2023 | ||
Pierre Legault | Director | $1.8M | Feb 5, 2025 | ||
Keith Katkin | Director | $1.8M | Feb 5, 2025 | ||
Jennifer Jarrett | Director | $1.8M | Feb 5, 2025 | ||
William Meury | Director | $1.8M | Feb 5, 2025 | ||
Martin H. Huber Jr. | Director | $1.48M | Feb 5, 2025 | ||
Aleksandra Rizo | Director | $1.28M | Feb 5, 2025 | ||
Michael L. Meyers | SVP, Chief Medical Officer | $874K | Feb 2, 2022 | ||
Briggs Morrison | Director | $636K | Feb 7, 2024 | ||
Fabrice Egros | Director | $584K | Feb 2, 2022 | ||
Alexander Nolte | Chief Accounting Officer | $439K | Feb 2, 2023 | ||
Peter Ordentlich | Chief Scientific Officer | Feb 15, 2023 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|